Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality … CL Harden, KJ Meador, PB Pennell, WA Hauser, GS Gronseth, JA French, ... Neurology 73 (2), 133, 2009 | 732* | 2009 |
Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy [RETIRED] Report of the Therapeutics and Technology Assessment Subcommittee and … JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ... Neurology 62 (8), 1261-1273, 2004 | 697 | 2004 |
Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy [RETIRED] Report of the Therapeutics and Technology Assessment Subcommittee and … JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ... Neurology 62 (8), 1252-1260, 2004 | 670 | 2004 |
A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly … L Taylor, B Gidal, G Blakey, B Tayo, G Morrison CNS drugs 32, 1053-1067, 2018 | 452 | 2018 |
Enzyme induction with antiepileptic drugs: cause for concern? MJ Brodie, S Mintzer, AM Pack, BE Gidal, CJ Vecht, D Schmidt Epilepsia 54 (1), 11-27, 2013 | 441 | 2013 |
Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding … CL Harden, PB Pennell, BS Koppel, CA Hovinga, B Gidal, KJ Meador, ... Neurology 73 (2), 142-149, 2009 | 344 | 2009 |
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development … AM Kanner, E Ashman, D Gloss, C Harden, B Bourgeois, JF Bautista, ... Neurology 91 (2), 74-81, 2018 | 342 | 2018 |
Practice Parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency … CL Harden, J Hopp, TY Ting, PB Pennell, JA French, WA Hauser, ... Neurology 73 (2), 126-132, 2009 | 327 | 2009 |
Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. P Wiegartz, M Seidenberg, A Woodard, B Gidal, B Hermann Neurology 53 (5 Suppl 2), S3-8, 1999 | 289 | 1999 |
Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies. DJ Black, KL Kunze, LC Wienkers, BE Gidal, TL Seaton, ND McDonnell, ... Drug metabolism and disposition 24 (4), 422-428, 1996 | 234 | 1996 |
Management issues for women with epilepsy—Focus on pregnancy (an evidence‐based review): III. Vitamin K, folic acid, blood levels, and breast‐feeding: Report of the Quality … CL Harden, PB Pennell, BS Koppel, CA Hovinga, B Gidal, KJ Meador, ... Epilepsia 50 (5), 1247-1255, 2009 | 219 | 2009 |
Fractures, epilepsy, and antiepileptic drugs RH Mattson, BE Gidal Epilepsy & Behavior 5, 36-40, 2004 | 191 | 2004 |
Efficacy and tolerability of the new antiepileptic drugs, I: treatment of new‐onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and … JA French, AM Kanner, J Bautista, B Abou‐Khalil, T Browne, CL Harden, ... Epilepsia 45 (5), 401-409, 2004 | 178 | 2004 |
Management issues for women with epilepsy—Focus on pregnancy (an evidence‐based review): I. Obstetrical complications and change in seizure frequency: Report of the Quality … CL Harden, J Hopp, TY Ting, PB Pennell, JA French, W Allen Hauser, ... Epilepsia 50 (5), 1229-1236, 2009 | 173 | 2009 |
Bidirectional interaction of valproate and lamotrigine in healthy subjects GD Anderson, MK Yau, BE Gidal, SJ Harris, RH Levy, AA Lai, KB Wolf, ... Clinical Pharmacology & Therapeutics 60 (2), 145-156, 1996 | 172 | 1996 |
Efficacy and tolerability of the new antiepileptic drugs, II: treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and … JA French, AM Kanner, J Bautista, B Abou‐Khalil, T Browne, CL Harden, ... Epilepsia 45 (5), 410-423, 2004 | 170 | 2004 |
Refractory status epilepticus: response to ketamine RD Sheth, BE Gidal Neurology 51 (6), 1765-1766, 1998 | 169 | 1998 |
Inter-and intra-subject variability in gabapentin absorption and absolute bioavailability BE Gidal, LL Radulovic, S Kruger, P Rutecki, M Pitterle, HN Bockbrader Epilepsy research 40 (2-3), 123-127, 2000 | 167 | 2000 |
Concentration–effect relationships with perampanel in patients with pharmacoresistant partial‐onset seizures BE Gidal, J Ferry, O Majid, Z Hussein Epilepsia 54 (8), 1490-1497, 2013 | 153 | 2013 |
Bone disease associated with antiepileptic drugs. AM Pack, B Gidal, B Vazquez Cleveland clinic journal of medicine 71, S42-8, 2004 | 151 | 2004 |